Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity
- PMID: 15175020
- DOI: 10.1111/j.1399-3011.2004.00157.x
Nonpeptide/peptide chimeric ligands for the nociceptin/orphanin FQ receptor: design, synthesis and in vitro pharmacological activity
Abstract
Nociceptin/orphanin FQ (N/OFQ) is the endogenous ligand for the G-protein coupled receptor referred to as N/OFQ peptide (NOP) receptor. NOP receptor activation by N/OFQ modulates several biological functions both at central and peripheral level. Structure activity relationship (SAR) studies demonstrated that the N/OFQ sequence can be divided into a N-terminal tetrapeptide 'message' crucial for receptor activation and a C-terminal 'address' important for receptor binding. On the basis of this message/address concept we synthesized some chimeric compounds in which we substituted the natural message domain with the nonselective nonpeptide NOP ligand (8-Naphthalen-1-yl-methyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4,5]dec-3-yl)-aceticacid methyl ester (NNC 63-0532) and used as address domain the peptide sequences Thr-NH2, N/OFQ(5-9)-NH2, N/OFQ(5-13)-NH2 and N/OFQ(5-17)-NH2. All the compounds were pharmacologically evaluated in the electrically stimulated guinea-pig ileum. NNC 63-0532 produced a concentration-dependent inhibition of the electrically induced twitches showing, in comparison with N/OFQ, lower potency and higher maximal effects. In addition, contrary to N/OFQ, the effects of NNC 63-0532 were insensitive to the NOP selective antagonist [Nphe1, Arg14, Lys15]N/OFQ-NH2 (UFP-101) while prevented by naloxone. Similar results were obtained with NNC 63-0532/Thr-NH2 and NNC 63-0532/N/OFQ(1-9)-NH2. On the contrary, the inhibitory effects of NNC 63-0532/N/OFQ(5-13)-NH2 and NNC 63-0532/N/OFQ(5-17)-NH2 were slightly antagonized by UFP-101 while naloxone prevented the effects of the high but not of the low concentrations of the two ligands. These data indicate that it is possible to functionalize with the N/OFQ address sequence a nonpeptide NOP ligand for increasing its binding to the NOP receptor. Moreover, these results corroborate the idea that the 5-13 sequence represents the crucial core of the N/OFQ address domain.
Similar articles
-
Novel potent agonist [(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 and antagonist [Nphe1,(pF)Phe4,Aib7,Aib11,Arg14,Lys15]N/OFQ-NH2 of nociceptin/orphanin FQ receptor.Regul Pept. 2006 May 15;134(2-3):75-81. doi: 10.1016/j.regpep.2006.01.003. Epub 2006 Mar 6. Regul Pept. 2006. PMID: 16516988
-
[Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.Br J Pharmacol. 2002 May;136(2):303-11. doi: 10.1038/sj.bjp.0704706. Br J Pharmacol. 2002. PMID: 12010780 Free PMC article.
-
The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functions.Peptides. 2005 Sep;26(9):1590-7. doi: 10.1016/j.peptides.2005.02.018. Epub 2005 Mar 19. Peptides. 2005. PMID: 16112397
-
The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.Pharmacol Ther. 2014 Mar;141(3):283-99. doi: 10.1016/j.pharmthera.2013.10.011. Epub 2013 Nov 1. Pharmacol Ther. 2014. PMID: 24189487 Free PMC article. Review.
-
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor.CNS Drug Rev. 2005 Summer;11(2):97-112. doi: 10.1111/j.1527-3458.2005.tb00264.x. CNS Drug Rev. 2005. PMID: 16007234 Free PMC article. Review.
Cited by
-
Pharmacological profile of NOP receptors coupled with calcium signaling via the chimeric protein G alpha qi5.Naunyn Schmiedebergs Arch Pharmacol. 2009 Jun;379(6):599-607. doi: 10.1007/s00210-009-0396-x. Epub 2009 Jan 28. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 19183962
-
Discovery of Novel, Selective, and Nonbasic Agonists for the Kappa-Opioid Receptor Determined by Salvinorin A-Based Virtual Screening.J Med Chem. 2024 Aug 22;67(16):13788-13801. doi: 10.1021/acs.jmedchem.4c00590. Epub 2024 Aug 1. J Med Chem. 2024. PMID: 39088801 Free PMC article.
-
Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligands.Sci Rep. 2017 Apr 6;7:45817. doi: 10.1038/srep45817. Sci Rep. 2017. PMID: 28383520 Free PMC article.
-
Probing non-peptide agonists binding at the human nociceptin/orphanin FQ receptor: a molecular modelling study.RSC Med Chem. 2024 Dec 10. doi: 10.1039/d4md00747f. Online ahead of print. RSC Med Chem. 2024. PMID: 39790123 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous